
What does -floxacin mean?
The -floxacin stem marks a fluoroquinolone inhibiting DNA gyrase. Why tendon rupture, QT prolongation and the chelation interaction all follow from the class.

Short answer: A drug ending in -prazole is a proton pump inhibitor: it disables the H+/K+ ATPase in the gastric parietal cell, the final step every acid-stimulating signal has to pass through. Because the binding is irreversible, the effect outlasts the drug in the blood by more than a day, which is why plasma half-life predicts almost nothing useful about it.
Generic drug names are not invented freely. The USAN Council assigns stems so that related compounds share a family name, stating plainly that the purpose is to make prescribing safer by giving immediate recognition. The WHO INN Stem Book does the same job internationally. The -prazole stem was assigned to the substituted benzimidazoles, which share both a chemical skeleton and a mechanism. That double meaning is unusual and it is why this stem is so reliable: unlike some older endings, it tells you the chemistry and the target at once.
The parietal cell is stimulated by histamine, acetylcholine and gastrin, each through its own receptor. Blocking any one of them removes a third of the input, which is why H2 blockers reduce acid without abolishing it. The proton pump is where all three pathways converge, so disabling it stops secretion no matter which signal is arriving. Acting at a point of convergence rather than on one input is the general reason this class is so much more powerful than the one it displaced.
A proton pump inhibitor binds the pump covalently, so recovery does not depend on the drug being cleared. It depends on the cell manufacturing new pumps, which takes far longer. That is why a drug with a plasma half-life of about an hour suppresses acid for more than a day. It is the cleanest example in pharmacology of half-life predicting duration only when binding is reversible, and it is worth learning for that lesson alone.
These drugs are inactive as given. They are weak bases that accumulate in the only strongly acidic compartment in the body, the secretory canaliculus of an active parietal cell, where acid converts them into the reactive form that binds the pump. That targeting is elegant: the drug activates itself only where it is needed. It also explains why an acid-suppressed stomach reduces their own activation, which is part of why doses are not simply escalated.
Only pumps that are actively secreting can be hit, and the largest proportion are active shortly after a meal begins. Taking the dose thirty to sixty minutes before food puts drug in the blood at the moment the most pumps are exposed. Taking it after food, or at bedtime on an empty stomach, wastes a share of the dose on pumps that are dormant. This single counselling point accounts for a good deal of apparent treatment failure.
Most of this class is metabolised by CYP2C19, which matters in two directions. Genetic variation in that enzyme changes how much drug a person is exposed to, with poor metabolisers reaching higher levels. More importantly, omeprazole inhibits CYP2C19, and clopidogrel is a prodrug that requires CYP2C19 to become active. Combining them can blunt antiplatelet effect, which is why pantoprazole is often preferred in that situation.
Profound acid suppression is not free. Acid aids absorption of magnesium, vitamin B12, calcium and iron, and it is also a barrier to swallowed organisms, so long courses are associated with hypomagnesaemia, B12 deficiency and enteric infection. None of these argues against using the drugs where they are indicated. They argue against continuing them out of habit once the indication has passed, which is the commonest prescribing error in this class.
All members share the mechanism, so what separates them is metabolism and interaction profile rather than potency at the pump.
| Drug | Notable property | Where it matters |
|---|---|---|
| Omeprazole | Potent CYP2C19 inhibitor | The clopidogrel interaction |
| Esomeprazole | S-isomer of omeprazole | Similar interaction profile |
| Lansoprazole | Moderate CYP involvement | Widely used, fewer restrictions |
| Pantoprazole | Least CYP2C19 inhibition | Preferred alongside clopidogrel |
| Rabeprazole | Largely non-enzymatic metabolism | Less affected by CYP2C19 genotype |
A question that offers an unfamiliar -prazole is not testing whether you have memorised that drug. It is testing whether you can place it, and the stem does that for you. From the class alone you can predict the mechanism, that the onset is slower than an H2 blocker, that the dose belongs before food, and that a clopidogrel interaction is worth checking. That is four marks from four letters.
Potassium-competitive acid blockers such as vonoprazan also target the same pump but bind reversibly and do not carry the -prazole stem in the same way. They reach maximal suppression faster and are not dependent on acid activation. The stem remains reliable for the benzimidazoles, but it is a reminder that a stem describes a chemical family rather than every drug that hits a target.
Only the pumps active at the moment the drug is circulating get disabled, and the parietal cell holds a reserve that is recruited over subsequent meals. Each dose therefore takes out a further tranche, and maximal acid suppression arrives after roughly three to five days of regular dosing rather than after the first tablet. Patients told to expect immediate relief often conclude the drug has failed and stop it on day two, which makes this a counselling point rather than a piece of trivia.
Sustained acid suppression raises gastrin, because the feedback loop that normally restrains it depends on acid being present. Gastrin is trophic to the parietal cell mass, so prolonged treatment leaves the stomach with more acid-producing capacity than it started with. Withdraw the drug suddenly and that expanded capacity is unopposed, producing rebound hypersecretion for a period of weeks. The symptoms are easily mistaken for the original disease returning, which is how short courses quietly become permanent ones.
The intravenous route is used where the oral one is unavailable or where very rapid, profound suppression is wanted, most familiarly around upper gastrointestinal bleeding. For simple ulcer healing or reflux, oral dosing achieves the same result, because absorption is good and the binding is irreversible either way. Reaching for the injectable form when a tablet would do adds cost and cannula risk without adding benefit, which is a recurring theme in prescribing questions.
An antacid neutralises acid already secreted and works within minutes but lasts barely an hour. An H2 blocker removes one of three stimulatory signals and works within an hour with moderate suppression. A proton pump inhibitor disables the final common step and gives profound, sustained suppression with a slow onset. Matching the drug to the pattern of symptoms, rather than defaulting to the most powerful option, is the actual clinical skill being examined.
The clearest way to fix this class is against the one it replaced, so read our comparison of a proton pump inhibitor with an H2 blocker in omeprazole versus famotidine, then check how the CYP2C19 interaction fits the wider enzyme picture. The stem hub collects every ending in one place, and the practice questions will tell you whether it has actually stuck.
The method below works for any generic name, which is the point of learning naming as a system rather than learning drugs one at a time. Start at the end of the word, because that is where the stem almost always sits, and read backwards until you reach something familiar. Endings are assigned; beginnings are usually the manufacturer distinguishing one compound from its siblings, so the front of the name carries far less information.
Next, ask what the stem predicts. A good stem gives you a target or a chemical family, and from either you can usually derive the main effect and the principal side effect, because most adverse effects are the intended action appearing in a tissue where it was not wanted. Then look deliberately for the exception, since every stem has one and exams are built on exactly those cases.
Finally, check rather than assume. A stem narrows the possibilities; it does not replace the label. Drugs that share a target can carry different stems if their chemistry differs, and drugs that share a stem can differ enormously in duration, which is frequently the property that decides how each is used. Treat the ending as a strong hypothesis that gets you most of the way to an answer, then confirm the detail against a primary source before it matters clinically.
It marks a proton pump inhibitor, a substituted benzimidazole that irreversibly disables the H+/K+ ATPase in the gastric parietal cell. The stem tells you both the chemistry and the target, which is unusual and makes it unusually reliable.
Only actively secreting pumps can be bound, and the largest proportion become active shortly after a meal begins. Dosing thirty to sixty minutes beforehand puts drug in the blood when the most pumps are exposed.
Because it binds the pump irreversibly. Recovery requires the cell to make new pumps rather than simply clearing the drug, so a plasma half-life of about an hour produces more than a day of acid suppression.
Pantoprazole is usually preferred because it inhibits CYP2C19 least. Clopidogrel is a prodrug needing CYP2C19 for activation, so a strong inhibitor such as omeprazole can reduce its antiplatelet effect.
They are effective and widely tolerated, but prolonged acid suppression is associated with low magnesium, vitamin B12 deficiency and a higher rate of enteric infection. The practical issue is usually continuing them after the indication has passed rather than the drugs themselves.
Four letters at the end of a name give you a mechanism, a dosing instruction, an interaction to check and a reason the half-life is misleading. That is what a well-chosen stem buys, and it is why learning the naming system is a better investment than learning drugs one at a time. Meet an unfamiliar -prazole in an exam and you already know most of what the question wants.
For study only. This article is written for learning and examination practice. It is not medical advice, not clinical decision support, and must never be used to make a decision about a real patient. Always verify against your local formulary, the product literature and a qualified pharmacist.
One mechanism explained properly every day, then brought back before you forget it.
Free to download. 7-day Pro trial. No credit card.